Gus Bilirakis actually said...

"Anybody that argues that prices go down or stability increases as a result of renewable portfolio standards is being disingenuous."

"this is accountability. Are you investigating this? Will the people responsible, the administrators, be held responsible?"

"Would it improve the standard of care to have these indications on the label, such as ensuring correct dosage and access to insurance reimbursement?"

"I think the best way to do that is to ask the FDA or direct the FDA by legislation, or statute, or regulation changes, to allow that communication to go forward."